Please try another search
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Edward Karol Sikora | 71 | - | Member of Scientific Advisory Board |
Jane Mellor | - | - | Member of Scientific Advisory Board |
Ooi Peng-Jin | - | - | Member of Scientific Advisory Board |
Stephen Charles Diggle | 57 | 2016 | Non-Executive Director |
Iain B. McInnes | - | 2019 | Member of Scientific Advisory Board |
David M. A. Holbrook | 61 | 2019 | Independent Non-Executive Director |
Matthew Anthony Wakefield | 61 | 2020 | Independent Non-Executive Chairman |
Paul Leslie Stockdale | 48 | 2017 | CFO & Executive Director |
Alexandre Akoulitchev | 61 | 2007 | Chief Scientific Officer & Executive Director |
Jon Anthony Joseph Burrows | 60 | 2020 | CEO & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review